Health Catalyst (HCAT) Tops Q3 EPS by 6c

Health Catalyst (NASDAQ: HCAT) reported Q3 EPS of ($0.21), $0.06 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $47.2 million versus the consensus estimate of $44.59 million.

For earnings history and earnings-related data on Health Catalyst (HCAT) click here.

You May Also Be Interested In

• Gilead Sciences (GILD) Misses Q1 EPS by 288c
• COPT Defense Properties (CDP) Reports In-Line Q1 EPS; offers guidance
• ResMed (RMD) Tops Q3 EPS by 20c